A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

NCT00287066 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetes Mellitus

Interventions

DRUG: Inhaled Human Insulin
DRUG: Regular Human Insulin

Sponsor

Pfizer